Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02566902 · ClinicalTrials.gov registry record · NA

Comparison of Breath-Enhanced and T-Piece Nebulizers in Children With Acute Asthma

A NA study of Asthma, sponsored by Seton Healthcare Family.

Completed
Registry status
NA
Development phase
118
Enrollment target
1
Study location

NCT02566902: Completed NA study of Asthma, sponsored by Seton Healthcare Family.

NCT02566902 is a NA study of Asthma that has completed, run by Seton Healthcare Family. The registered enrollment target is 118 participants, below the 1,563-participant average among 374 other Asthma trials with a reported enrollment target (92% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02566902, a NA study of Asthma, has completed, sponsored by Seton Healthcare Family.

COMPLETED
Registry status
NA
Development phase
118 participants
Enrollment target
1
Study location

Study Summary

This is a blinded observer randomized controlled trial comparing two nebulizer devices. The objective of this study is to evaluate the efficacy of two different nebulizers.

Primary Outcome

Pre-treatment spirometry measurement assessed at the time of study enrollment. Post-treatment spirometry measurement assessed following the administration of one time 5mg nebulized albuterol sulfate treatment. Assessments taken at baseline (prior to albuterol therapy) and 10 min post-treatment. Change in FEV1 calculated as post-treatment FEV1 minus pre-treatment FEV1

Conditions Studied

Interventions

  • DRUG Albuterol
  • DEVICE T-Piece Nebulizer
  • DEVICE Breath-Enhanced Nebulizer
  • PROCEDURE Pre-Treatment Spirometry Measurement
  • PROCEDURE Post-Treatment Spirometry Measurement

Study Locations (1)

Texas

  • Dell Children's Medical Center, Emergency Department - Austin

Trial Details

FieldValue
Enrollment Target 118 participants
Start Date 2015-10
Est. Completion 2017-06-30
Phase NA
Seton Healthcare Family

15 total trials

What the finished NCT02566902 record still lists

NCT02566902 is an interventional study that assigns participants to a tested intervention. The registered 118 participants enrollment target is mid-sized for trials with a published cap, below the 1,563-participant average among 374 other Asthma trials with a reported enrollment target (92% lower).

The record links to 1 condition, with Asthma appearing as the primary indexed condition, and to 5 interventions - of which Albuterol is the first listed.

NCT02566902 reports a single indexed study location in Texas.

Frequently Asked Questions

What is clinical trial NCT02566902 about?

NCT02566902 is a clinical study titled "Comparison of Breath-Enhanced and T-Piece Nebulizers in Children With Acute Asthma". This is a blinded observer randomized controlled trial comparing two nebulizer devices. The objective of this study is to evaluate the efficacy of two different nebulizers.

What is the current status of trial NCT02566902?

This trial is currently completed. It is a NA study. The enrollment target is 118 participants. The study started on 2015-10. Estimated completion is 2017-06-30.

What conditions does trial NCT02566902 study?

This clinical trial studies the following conditions: Asthma.

What interventions are being tested in trial NCT02566902?

The interventions under investigation include: Albuterol (DRUG), T-Piece Nebulizer (DEVICE), Breath-Enhanced Nebulizer (DEVICE), Pre-Treatment Spirometry Measurement (PROCEDURE), Post-Treatment Spirometry Measurement (PROCEDURE).

Who is sponsoring clinical trial NCT02566902?

This trial is sponsored by Seton Healthcare Family, which has 15 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02566902 being conducted?

This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Asthma

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT02566902's enrollment target sits among peer trials

118 201st of 374 higher than 173 of 374 other Asthma trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Asthma trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT03821623 · 118 participants · Phase 2

    Nicotinamide Riboside for Treating Elevated Systolic Blood Pressure and Arterial Stiffness in Middle-aged and Older Adults

  • NCT04040959 · 118 participants · Phase 2

    Nicotinamide Riboside Supplementation for Treating Arterial Stiffness and Elevated Systolic Blood Pressure in Patients With Moderate to Severe CKD

  • NCT04696029 · 118 participants · Phase 2

    DFMO as Maintenance Therapy for Molecular High/Very High Risk and Relapsed Medulloblastoma

  • NCT05223192 · 118 participants · NA

    The Effects of Entrainment on Respiratory Stability and Cerebral Oxygenation in Preterm Infants

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT02566902, the US trial registry maintained by the National Library of Medicine. NCT02566902 (mid enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.